Several stocks are currently undergoing noteworthy developments, making them worthy of closer monitoring. This feature will delve into five stocks that merit inclusion in watch lists, offering.
Ocean Biomedical (NASDAQ: OCEA) announced that its Scientific Co-founder, Jack Elias, co-authored new findings in the peer-reviewed journal Immunity that detail the mechanisms behind the role of chitinase 3-like-1 (CHI3L1) in the growth of triple-negative breast cancer.
Ocean Biomedical Inc (NASDAQ: OCEA) announced that the United States Patent and Trademark Office has issued a patent covering Ocean’s anti-Chitinase 1 small molecule candidate.